InsiderTrades

Form 4 for ELAN Elanco Animal Health Inc

Accepted 2022-03-03 00:00:00 ET · period of report 2022-03-01 · accession 0001415889-22-002472 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2022-03-03 2022-03-01+ ELAN Simmons Jeffrey N Pres, CEO AND Dir, Dir F - Tax $28.98 -13.9K 763.7K -2% -$403.1K
D 2022-03-03 2022-03-01 ELAN Simmons Jeffrey N Pres, CEO AND Dir, Dir A - Grant $0.00 +88.1K 777.6K +13% $0
D 2022-03-03 2022-03-01 ELAN Simmons Jeffrey N Pres, CEO AND Dir, Dir A - Grant $0.00 +234.2K 234.2K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-03-01 F D 5,031 $28.94 772,553 D — — (F2) Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the Amended and Restated 2018 Elanco Stock Plan.
2 Common Common Stock 2022-03-02 F D 8,879 $29.00 763,674 D — — (F2) Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the Amended and Restated 2018 Elanco Stock Plan.
3 Common Common Stock 2022-03-01 A A 88,114 $0.00 777,584 D — — (F1) Grant of restricted stock units pursuant to the Amended and Restated 2018 Elanco Stock Plan on March 1, 2022, one-third vesting on March 1, 2023, one-third vesting on March 1, 2024, and the remaining vesting on March 1, 2025.
4 Derivative Employee Stock Option(right to buy) 2022-03-01 A A 234,160 $0.00 234,160 D $28.94 · — to 2032-03-01 234,160 Common Stock (F3) Grant of stock options vesting as follows: one-third vesting on March 1, 2023, one-third vesting on March 1, 2024, and the remaining vesting on March 1, 2025.